HFPE stands for which pharmacokinetic concept?

Prepare for the MTM Pediatric Obesity Test with our comprehensive study aids. Use flashcards and multiple choice questions, each with detailed explanations and hints. Ensure you're ready for the exam!

Multiple Choice

HFPE stands for which pharmacokinetic concept?

Explanation:
The key idea is how the liver metabolizes a drug before it reaches the rest of the body, which is called hepatic first-pass metabolism. HFPE stands for hepatic first pass effect. When a drug is taken by mouth, it is absorbed from the gut and delivered to the liver via the portal vein. In the liver, enzymes can metabolize a portion of the drug before it enters systemic circulation, reducing the amount that actually becomes available to produce an effect. This hepatic first-pass activity explains why oral bioavailability can be quite low for some drugs and why dosing often needs to account for this loss or why alternative routes (like sublingual or IV) bypass it. Context helps: the extent of this effect depends on how strongly a drug is metabolized in the liver, the liver’s enzyme activity, and the liver’s blood flow. For example, drugs with extensive first-pass metabolism may require higher oral doses or alternate administration routes. This concept is distinct from hepatic perfusion evaluation, which relates to liver blood flow and clearance in a different context, and from hepatic protein binding or other terms that describe distribution or binding rather than first-pass metabolism.

The key idea is how the liver metabolizes a drug before it reaches the rest of the body, which is called hepatic first-pass metabolism. HFPE stands for hepatic first pass effect. When a drug is taken by mouth, it is absorbed from the gut and delivered to the liver via the portal vein. In the liver, enzymes can metabolize a portion of the drug before it enters systemic circulation, reducing the amount that actually becomes available to produce an effect. This hepatic first-pass activity explains why oral bioavailability can be quite low for some drugs and why dosing often needs to account for this loss or why alternative routes (like sublingual or IV) bypass it.

Context helps: the extent of this effect depends on how strongly a drug is metabolized in the liver, the liver’s enzyme activity, and the liver’s blood flow. For example, drugs with extensive first-pass metabolism may require higher oral doses or alternate administration routes. This concept is distinct from hepatic perfusion evaluation, which relates to liver blood flow and clearance in a different context, and from hepatic protein binding or other terms that describe distribution or binding rather than first-pass metabolism.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy